Completed OBSERVATIONAL NCT00230659

Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia

Investigation of Coagulation Parameters in Hereditary Haemorrhagic

Sponsor: Hammersmith Hospitals NHS Trust

Conditions Telangiectasia, Hereditary Hemorrhagic

Updated 7 times since 2017 Last updated: Sep 25, 2023 Started: Aug 31, 2004 Primary completion: Jul 31, 2007 Completion: Jul 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Telangiectasia, Hereditary Hemorrhagic, this trial is completed. The trial is conducted by Hammersmith Hospitals NHS Trust and has accumulated 7 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Oct 2023 — Jul 2024 [monthly]

Completed
Jan 2021 — Oct 2023 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: PHASE4 → None
Jan 2017 — Apr 2018 [monthly]

Completed PHASE4

First recorded

Aug 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hammersmith Hospitals NHS Trust
Imperial College London

Data source: Imperial College London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom